Patient-derived heart cells mimic disease in vitro

Patient-derived heart cells mimic disease in vitro
Fig.1 Reduced contractility and impaired desmosome assembly in isogenic iPS cell-derived cardiomyocytes. (CC BY, © 2022 Hiroyuki Inoue et al., Modeling reduced contractility and impaired desmosome assembly due toplakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes. Credit: Stem Cell Reports

How can you mend a broken heart? According to researchers from Japan, in some cases gene replacement therapy just might do the trick.

In a study published in January in Stem Cell Reports, researchers from Osaka University report that heart cells from a patient with an inherited heart disease called arrhythmogenic cardiomyopathy do not contract correctly when grown in the laboratory, and that replacing the responsible for this effect fixes this defect.

Arrhythmogenic cardiomyopathy occurs due to mutations in genes involved in desmosomes, which form 'welds' between cells that help them communicate and move in a coordinated way. One of these genes, PKP2, encodes a protein known as plakophilin-2 that is crucial to maintaining heart cell structure.

"Previous studies carried out in cardiomyocytes have shown that mutations in PKP2 play a pathological role in arrhythmogenic cardiomyopathy," says lead author of the study Hiroyuki Inoue. "However, the cells used in those experiments were derived from healthy individuals and were not assessed for contractile function."

To investigate how cells derived from patients behave in the laboratory, the researchers first took a from a young patient with arrhythmogenic cardiomyopathy, induced some of the to become , and then differentiated these stem cells into heart cells. They then modified this original batch of into three different cell lines with precisely adjusted PKP2 expression based on how many mutated or intact copies of the gene were present.

Patient-derived heart cells mimic disease in vitro
Fig.2 Fluorescent labeling of DSG2 captures desmosome dynamics. (CC BY, © 2022 Hiroyuki Inoue et al., Modeling reduced contractility and impaired desmosome assembly due toplakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes. Credit: Stem Cell Reports

"The cells with two mutated copies of PKP2 clearly exhibited reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency," explains Shuichiro Higo, senior author. "These effects were also observed in with only one mutated copy of PKP2, although they were less severe."

Replacing the mutated PKP2 with an intact copy of the gene repaired the defects in both cell contraction and desmosome assembly, which the researchers were able to observe using a time-lapse approach and fluorescently labeled desmosomes.

Patient-derived heart cells mimic disease in vitro
Fig.3 Gene delivery of PKP2 recovered contractility and desmosome assembly. (CC-BY, © 2022 Hiroyuki Inoue et al., Modeling reduced contractility and impaired desmosome assembly due toplakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes. Credit: Stem Cell Reports

"These findings suggest that our cardiomyocyte cell lines recapitulate the pathology of arrhythmogenic cardiomyopathy and provide a rapid and convenient platform for developing gene-based therapies for this disease," says Higo.

Given that PKP2 is the most common gene associated with arrhythmogenic cardiomyopathy, and that PKP2 mutations can lead to severe disease, new therapeutic approaches could help halt disease progression. The findings from this study suggest that gene replacement therapy could be a valuable way of treating patients with this condition and the created in this study are a viable model to test new therapies for arrhythmogenic cardiomyopathy.


Explore further

Calcium: Important not just for your bones but also for your heart

More information: Hiroyuki Inoue et al, Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes, Stem Cell Reports (2022). DOI: 10.1016/j.stemcr.2021.12.016
Journal information: Stem Cell Reports

Provided by Osaka University
Citation: Patient-derived heart cells mimic disease in vitro (2022, January 24) retrieved 28 May 2022 from https://medicalxpress.com/news/2022-01-patient-derived-heart-cells-mimic-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors